Novartis AG announced the appointment of Mukul Mehta as Chief Financial Officer, effective March 16, 2026. Mehta, currently Head of Business Planning and Analysis, Digital Finance and Tax, will replace Harry Kirsch, who is retiring after 22 years with the company. Mehta has over 20 years of experience at Novartis, holding key finance leadership roles across various geographies and business units.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.